- Sanofi to buy Belgian biotech company Ablynx for $4.8 bn 29 January 2018
- Drugmaker Sanofi under fire over Dengvaxia reverse 18 December 2017
- WHO to review Sanofi's dengue vaccine Dengvaxia over safety concerns 05 December 2017
- FDA approves Dupixent to treat severe eczema 29 March 2017
- Sanofi nears deal to sell some OTC products to Ipsen SA 13 February 2017
- Regeneron and Sanofi need not pull Praluent off market 09 February 2017
- Sanofi mulls counter bid for Swiss biotech company Actelion 06 December 2016
- New cholesterol drug not worth the high price, finds study 19 August 2016
- Sanofi prepares to replace Medivation's board 14 May 2016
- Sanofi tables $9.3-bn bid for US biotech firm Medivation 28 April 2016
- French drug maker Sanofi recalls epinephrine injectors 02 November 2015
- Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa 21 September 2015
- Sanofi Emcure in pact to market oncology drugs 06 August 2014
- Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada 30 December 2013
- Sanofi, Shire eye US rare diseases drug maker ViroPharma 14 September 2013
- Andhra HC quashes tax demand on Sanofi over Shantha Biotech buyout 15 February 2013
- INDOX expansion boosts cancer research across India 04 February 2013
- Sanofi to acquire Colombian affordable drugmaker Genfar 03 October 2012
- Sanofi to eliminate 900 R&D jobs in France 26 September 2012
- Lupin, Sanofi-Aventis Philippines in strategic agreement 05 September 2011
- Sanofi plans Rs450-cr OTC deal with Universal Medicare 23 August 2011
- Sanofi-Aventis shortens name to Sanofi 07 May 2011
- Sanofi-Aventis, Genzyme in talks to structure $80 per share deal 08 January 2011
- Sanofi-Aventis extends Genzyme offer, terms unchanged 13 December 2010
- Aventis to exit Chiron JV with Novartis, with Rs105-crore stake sale 13 December 2010
- Sanofi-Aventis goes hostile with $18.5-bn Genzyme bid 04 October 2010
- Sanofi Aventis reportedly raises offer to $71 per share 09 September 2010
- Sanofi-Aventis reveals $18.5-billion offer for Genzyme 30 August 2010
- Genzyme begins takeover talks with Sanofi-Aventis 03 August 2010
- Sanofi-Aventis concludes Chattem acquisition 13 March 2010
- Sanofi-Aventis commences tender offer for Chattem 11 January 2010
- Sanofi-aventis to acquire Chattem for $1.9 billion 21 December 2009
- Sanofi-Aventis signs drug localisation pact with Russia 28 November 2009
- Sanofi-Aventis expands Regeneron research deal to $1 billion 11 November 2009
- PPF ends opposition to Zentiva sale; Sanofi takeover likely 11 February 2009
- Sanofi settles Allegra, Nasacort patent suits with Teva, Barr 20 November 2008
- French drug giant Sanofi-Aventis opens R&D centre in Goa 05 December 2007
